| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.34e-06 | 5 | 140 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 1.44e-04 | 15 | 140 | 3 | GO:0015651 | |
| GeneOntologyMolecularFunction | amino-acid betaine transmembrane transporter activity | 2.90e-04 | 4 | 140 | 2 | GO:0015199 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.01e-04 | 46 | 140 | 4 | GO:0005245 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 1.05e-05 | 7 | 142 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 4.87e-05 | 11 | 142 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 2.72e-04 | 4 | 142 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 2.72e-04 | 4 | 142 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | multivesicular body | 3.36e-04 | 88 | 142 | 5 | GO:0005771 | |
| GeneOntologyCellularComponent | late endosome | 6.36e-04 | 348 | 142 | 9 | GO:0005770 | |
| Domain | FN3 | IL12RB1 MYOM1 OBSCN RIMBP3 TYRO3 PTPRB PTPRS RIMBP3C RIMBP2 OSMR RIMBP3B | 3.35e-07 | 199 | 141 | 11 | PS50853 |
| Domain | FN3_dom | IL12RB1 MYOM1 OBSCN RIMBP3 TYRO3 PTPRB PTPRS RIMBP3C RIMBP2 OSMR RIMBP3B | 5.47e-07 | 209 | 141 | 11 | IPR003961 |
| Domain | FN3 | IL12RB1 MYOM1 OBSCN TYRO3 PTPRB PTPRS RIMBP3C RIMBP2 OSMR RIMBP3B | 1.43e-06 | 185 | 141 | 10 | SM00060 |
| Domain | - | FCRL2 IL12RB1 MYOM1 NXPE4 OBSCN PKHD1L1 RIMBP3 TYRO3 CEACAM19 PTPRB PTPRS RIMBP3C ILDR1 RIMBP2 OSMR RIMBP3B CD96 | 1.08e-05 | 663 | 141 | 17 | 2.60.40.10 |
| Domain | Aspartic_peptidase_N | 1.44e-05 | 7 | 141 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 1.44e-05 | 7 | 141 | 3 | PF07966 | |
| Domain | Ig-like_fold | FCRL2 IL12RB1 MYOM1 NXPE4 OBSCN PKHD1L1 RIMBP3 TYRO3 CEACAM19 PTPRB PTPRS RIMBP3C ILDR1 RIMBP2 OSMR RIMBP3B CD96 | 2.42e-05 | 706 | 141 | 17 | IPR013783 |
| Domain | fn3 | 3.21e-05 | 162 | 141 | 8 | PF00041 | |
| Domain | Aspartic_peptidase_A1 | 4.86e-05 | 10 | 141 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 4.86e-05 | 10 | 141 | 3 | IPR033121 | |
| Domain | Asp | 4.86e-05 | 10 | 141 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 4.86e-05 | 10 | 141 | 3 | PS51767 | |
| Domain | - | 8.82e-05 | 12 | 141 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 8.82e-05 | 12 | 141 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 1.14e-04 | 13 | 141 | 3 | IPR001969 | |
| Domain | cNMP | 1.21e-04 | 34 | 141 | 4 | SM00100 | |
| Domain | cNMP_binding | 1.21e-04 | 34 | 141 | 4 | PF00027 | |
| Domain | cNMP-bd_dom | 1.36e-04 | 35 | 141 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.36e-04 | 35 | 141 | 4 | PS50042 | |
| Domain | cNMP-bd-like | 1.88e-04 | 38 | 141 | 4 | IPR018490 | |
| Domain | SH3 | 2.39e-04 | 216 | 141 | 8 | PS50002 | |
| Domain | Peptidase_aspartic_dom | 2.65e-04 | 17 | 141 | 3 | IPR021109 | |
| Domain | SH3_domain | 2.70e-04 | 220 | 141 | 8 | IPR001452 | |
| Domain | SH3_9 | 3.10e-04 | 78 | 141 | 5 | PF14604 | |
| Domain | Helicase_C_2 | 3.36e-04 | 4 | 141 | 2 | PF13307 | |
| Domain | DEAD_2 | 3.36e-04 | 4 | 141 | 2 | PF06733 | |
| Domain | PINIT | 3.36e-04 | 4 | 141 | 2 | PS51466 | |
| Domain | DEAD_2 | 3.36e-04 | 4 | 141 | 2 | IPR010614 | |
| Domain | ATP-dep_Helicase_C | 3.36e-04 | 4 | 141 | 2 | IPR006555 | |
| Domain | Helicase-like_DEXD_c2 | 3.36e-04 | 4 | 141 | 2 | IPR006554 | |
| Domain | PINIT | 3.36e-04 | 4 | 141 | 2 | PF14324 | |
| Domain | cAMP_dep_PK_reg_su | 3.36e-04 | 4 | 141 | 2 | IPR012198 | |
| Domain | DNA_helicase_DNA-repair_Rad3 | 3.36e-04 | 4 | 141 | 2 | IPR013020 | |
| Domain | PINIT | 3.36e-04 | 4 | 141 | 2 | IPR023321 | |
| Domain | HELICASE_ATP_BIND_2 | 3.36e-04 | 4 | 141 | 2 | PS51193 | |
| Domain | Helic_SF1/SF2_ATP-bd_DinG/Rad3 | 3.36e-04 | 4 | 141 | 2 | IPR014013 | |
| Domain | DEXDc2 | 3.36e-04 | 4 | 141 | 2 | SM00488 | |
| Domain | HELICc2 | 3.36e-04 | 4 | 141 | 2 | SM00491 | |
| Domain | - | 4.68e-04 | 48 | 141 | 4 | 2.60.120.10 | |
| Domain | SH3_2 | 4.87e-04 | 86 | 141 | 5 | PF07653 | |
| Domain | SH3_2 | 4.87e-04 | 86 | 141 | 5 | IPR011511 | |
| Domain | Nlgn | 5.58e-04 | 5 | 141 | 2 | IPR000460 | |
| Domain | RmlC-like_jellyroll | 5.91e-04 | 51 | 141 | 4 | IPR014710 | |
| Domain | Glycoside_hydrolase_SF | 6.84e-04 | 53 | 141 | 4 | IPR017853 | |
| Domain | LCCL | 8.32e-04 | 6 | 141 | 2 | PS50820 | |
| Domain | PbH1 | 8.32e-04 | 6 | 141 | 2 | SM00710 | |
| Domain | RIIa | 8.32e-04 | 6 | 141 | 2 | SM00394 | |
| Domain | LCCL | 8.32e-04 | 6 | 141 | 2 | SM00603 | |
| Domain | LCCL | 8.32e-04 | 6 | 141 | 2 | PF03815 | |
| Domain | LCCL | 8.32e-04 | 6 | 141 | 2 | IPR004043 | |
| Domain | - | 8.32e-04 | 6 | 141 | 2 | 2.170.130.20 | |
| Domain | PbH1 | 8.32e-04 | 6 | 141 | 2 | IPR006626 | |
| Domain | zf-MIZ | 1.16e-03 | 7 | 141 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 1.16e-03 | 7 | 141 | 2 | PS51044 | |
| Domain | RIIa | 1.16e-03 | 7 | 141 | 2 | PF02197 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 1.16e-03 | 7 | 141 | 2 | IPR003529 | |
| Domain | SH3 | 1.28e-03 | 216 | 141 | 7 | SM00326 | |
| Domain | HEMATOPO_REC_L_F2 | 1.54e-03 | 8 | 141 | 2 | PS01353 | |
| Domain | Pectin_lyase_fold/virulence | 1.54e-03 | 8 | 141 | 2 | IPR011050 | |
| Domain | Znf_MIZ | 1.54e-03 | 8 | 141 | 2 | IPR004181 | |
| Domain | Orgcat_transp/SVOP | 1.97e-03 | 9 | 141 | 2 | IPR004749 | |
| Domain | - | 2.31e-03 | 35 | 141 | 3 | 3.20.20.80 | |
| Domain | Glyco_hydro_catalytic_dom | 2.93e-03 | 38 | 141 | 3 | IPR013781 | |
| Domain | Integrin_alpha | 2.98e-03 | 11 | 141 | 2 | PF00357 | |
| Domain | Carboxylesterase_B_CS | 4.18e-03 | 13 | 141 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 4.85e-03 | 14 | 141 | 2 | PS00941 | |
| Domain | COesterase | 4.85e-03 | 14 | 141 | 2 | PF00135 | |
| Domain | Ldl_recept_b | 4.85e-03 | 14 | 141 | 2 | PF00058 | |
| Domain | LDLRB | 4.85e-03 | 14 | 141 | 2 | PS51120 | |
| Domain | CarbesteraseB | 4.85e-03 | 14 | 141 | 2 | IPR002018 | |
| Domain | LY | 5.57e-03 | 15 | 141 | 2 | SM00135 | |
| Domain | cAMP_dep_PK_reg_su_I/II_a/b | 5.57e-03 | 15 | 141 | 2 | IPR003117 | |
| Domain | LDLR_classB_rpt | 5.57e-03 | 15 | 141 | 2 | IPR000033 | |
| Domain | cNMP-bd_CS | 6.34e-03 | 16 | 141 | 2 | IPR018488 | |
| Domain | Integrin_alpha_C_CS | 6.34e-03 | 16 | 141 | 2 | IPR018184 | |
| Domain | Gal_mutarotase_SF_dom | 7.15e-03 | 17 | 141 | 2 | IPR011013 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.37e-09 | 5 | 143 | 4 | 17855024 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MCPH1 STARD10 OBSCN AAK1 ATP8B1 JMJD1C HPS3 SH3BP4 PCNX2 PACS1 NLGN3 PTPDC1 PTPRB LATS2 PTPRS SH3PXD2A MICAL2 KLHL23 PRKAR1B MACF1 NLGN2 RAPGEF2 ANKS1A | 4.57e-08 | 1489 | 143 | 23 | 28611215 |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 26733684 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 7926498 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 9561228 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 21455714 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 19800305 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 6.81e-08 | 3 | 143 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 6.81e-08 | 3 | 143 | 3 | 2799289 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 6.81e-08 | 3 | 143 | 3 | 1968039 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 6.81e-08 | 3 | 143 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 6.81e-08 | 3 | 143 | 3 | 2229438 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 6.81e-08 | 3 | 143 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 6.81e-08 | 3 | 143 | 3 | 8244094 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 21407214 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 6774973 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 6.81e-08 | 3 | 143 | 3 | 22304859 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 24004680 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 6.81e-08 | 3 | 143 | 3 | 2227273 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 23034090 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 24125879 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 6.81e-08 | 3 | 143 | 3 | 3554488 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 23521833 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 6.81e-08 | 3 | 143 | 3 | 21989121 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 9855083 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 9797498 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 2478370 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 6.81e-08 | 3 | 143 | 3 | 10675278 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 3780036 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 6.81e-08 | 3 | 143 | 3 | 3839486 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 3467902 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 6.81e-08 | 3 | 143 | 3 | 2892778 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 24383519 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 6.81e-08 | 3 | 143 | 3 | 2831884 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 2032552 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 1812762 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 7923573 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 6.81e-08 | 3 | 143 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 6.81e-08 | 3 | 143 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 6.81e-08 | 3 | 143 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 6.81e-08 | 3 | 143 | 3 | 1956484 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 8540382 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 6.81e-08 | 3 | 143 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 6.81e-08 | 3 | 143 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 6.81e-08 | 3 | 143 | 3 | 21970995 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 20428942 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 9525001 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 7886402 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 17379991 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 21547904 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 2.71e-07 | 4 | 143 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 2.71e-07 | 4 | 143 | 3 | 11915945 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 8322031 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.71e-07 | 4 | 143 | 3 | 19091768 | |
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 2.71e-07 | 4 | 143 | 3 | 17136346 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 12698190 | ||
| Pubmed | 6.77e-07 | 5 | 143 | 3 | 22066020 | ||
| Pubmed | Integrins are required for the differentiation of visceral endoderm. | 2.35e-06 | 7 | 143 | 3 | 19118216 | |
| Pubmed | The structure and expression of the human neuroligin-3 gene. | 1.68e-05 | 2 | 143 | 2 | 10767552 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21695374 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 16469794 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 1448119 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21910182 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 18274826 | ||
| Pubmed | IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells. | 1.68e-05 | 2 | 143 | 2 | 12868002 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 27805570 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 2714789 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 19814996 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 2450560 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 3197840 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21606177 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 20020740 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 24858808 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 27363302 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 16333318 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21793125 | ||
| Pubmed | SLC22A4 and SLC22A5 gene polymorphisms and Crohn's disease in the Chinese Han population. | 1.68e-05 | 2 | 143 | 2 | 19659785 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 36479216 | ||
| Pubmed | Characterization of organic cation/carnitine transporter family in human sperm. | 1.68e-05 | 2 | 143 | 2 | 12788076 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21706137 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 22325173 | ||
| Pubmed | Molecular and functional characterization of organic cation/carnitine transporter family in mice. | 1.68e-05 | 2 | 143 | 2 | 11010964 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 27908619 | ||
| Pubmed | Crystal structure of human pepsin and its complex with pepstatin. | 1.68e-05 | 2 | 143 | 2 | 7663352 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 26980442 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12718440 | ||
| Cytoband | 3q13.13-q13.2 | 9.63e-06 | 2 | 143 | 2 | 3q13.13-q13.2 | |
| GeneFamily | Fibronectin type III domain containing | 1.11e-05 | 160 | 86 | 7 | 555 | |
| GeneFamily | Zinc fingers MIZ-type | 4.62e-04 | 7 | 86 | 2 | 85 | |
| GeneFamily | ATAC complex | 1.69e-03 | 13 | 86 | 2 | 1058 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | RELN ITGA5 JMJD1C PTPRB NISCH PRKAR1A MACF1 NID1 OSMR ANKS1A | 6.97e-06 | 304 | 143 | 10 | M39113 |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | 1.37e-05 | 198 | 143 | 8 | M7219 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 1.42e-05 | 199 | 143 | 8 | M7596 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 181 | 143 | 7 | 09a574a3257e25c8b05a2ab20623a6b07331411a | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 181 | 143 | 7 | ac4142aa93706b7067f63d2d38e2456859e60768 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.15e-06 | 183 | 143 | 7 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 188 | 143 | 7 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 188 | 143 | 7 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 188 | 143 | 7 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 189 | 143 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 189 | 143 | 7 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 189 | 143 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 189 | 143 | 7 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-06 | 192 | 143 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-06 | 192 | 143 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC2|ICU-SEP / Disease, condition lineage and cell class | 3.87e-06 | 200 | 143 | 7 | 09d5c3a3d2b42b15c769dc2bc14b6c0d5cc38f91 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 165 | 143 | 6 | 95866f7cc6eb1bb51a034a104a0eb2a53b0256f2 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 165 | 143 | 6 | f8bfe336b9a4460b9349c01acd0bd3167812662f | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 172 | 143 | 6 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 172 | 143 | 6 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-05 | 177 | 143 | 6 | 95760841b3f085d38c4926b258a33563d93a2016 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-05 | 180 | 143 | 6 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 181 | 143 | 6 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-05 | 182 | 143 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-05 | 182 | 143 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.08e-05 | 186 | 143 | 6 | 294839944266407c40ef86e1d3e0fce4652b70ff | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.17e-05 | 187 | 143 | 6 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 187 | 143 | 6 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 187 | 143 | 6 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 187 | 143 | 6 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.27e-05 | 188 | 143 | 6 | 5d6faf45a9c0794b0c30b0a0601c10afbb8aa9ed | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.27e-05 | 188 | 143 | 6 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 3.27e-05 | 188 | 143 | 6 | 15057036b46c9df621ec4955aa94ca3036245d45 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.27e-05 | 188 | 143 | 6 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 188 | 143 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.46e-05 | 190 | 143 | 6 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-05 | 191 | 143 | 6 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-05 | 191 | 143 | 6 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 3.57e-05 | 191 | 143 | 6 | 32381d353e40bce77a5b63c7bdbe360d27327d86 | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.78e-05 | 193 | 143 | 6 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.78e-05 | 193 | 143 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.78e-05 | 193 | 143 | 6 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 193 | 143 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 4.12e-05 | 196 | 143 | 6 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 196 | 143 | 6 | efeb272bc9e37e60d15d056b7574991c5c7501bc | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.24e-05 | 197 | 143 | 6 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 4.36e-05 | 198 | 143 | 6 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 4.36e-05 | 198 | 143 | 6 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 4.36e-05 | 198 | 143 | 6 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| Disease | Down syndrome (is_marker_for) | 1.29e-04 | 22 | 133 | 3 | DOID:14250 (is_marker_for) | |
| Disease | digestive system infectious disorder | 2.16e-04 | 26 | 133 | 3 | MONDO_0043424 | |
| Disease | hearing loss | 2.43e-04 | 67 | 133 | 4 | EFO_0004238 | |
| Disease | Coxsackievirus Infections | 2.99e-04 | 6 | 133 | 2 | C0010246 | |
| Disease | Myocarditis | 2.99e-04 | 6 | 133 | 2 | C0027059 | |
| Disease | Carditis | 2.99e-04 | 6 | 133 | 2 | C0869523 | |
| Disease | interleukin 10 measurement | 4.35e-04 | 78 | 133 | 4 | EFO_0004750 | |
| Disease | melanoma (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | acetylcarnitine measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0021038 | |
| Disease | butyrylcarnitine measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0020010 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.05e-04 | 150 | 133 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | smoking cessation | 7.02e-04 | 325 | 133 | 7 | EFO_0004319 | |
| Disease | nervonoylcarnitine (C24:1) measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0800549 | |
| Disease | unipolar depression, age at onset | 7.83e-04 | 40 | 133 | 3 | EFO_0003761, EFO_0004847 | |
| Disease | lignoceroylcarnitine (C24) measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0800541 | |
| Disease | response to virus | 1.08e-03 | 11 | 133 | 2 | GO_0009615 | |
| Disease | tryptophan betaine measurement | 1.29e-03 | 12 | 133 | 2 | EFO_0021017 | |
| Disease | hexanoylcarnitine measurement | 1.29e-03 | 12 | 133 | 2 | EFO_0021040 | |
| Disease | X-12707 measurement | 1.29e-03 | 12 | 133 | 2 | EFO_0800720 | |
| Disease | Colorectal Carcinoma | ERCC2 ATP7B AMDHD2 OBSCN SLC44A4 HPS3 STK11 PTPRS NID1 WDR49 | 1.34e-03 | 702 | 133 | 10 | C0009402 |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 1.42e-03 | 49 | 133 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.50e-03 | 50 | 133 | 3 | EFO_0022334 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.52e-03 | 13 | 133 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | homostachydrine measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0021164 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0800547 | |
| Disease | cerotoylcarnitine (C26) measurement | 1.52e-03 | 13 | 133 | 2 | EFO_0800542 | |
| Disease | cortical thickness | RELN B4GALNT1 MCPH1 NUP210L VIT JMJD1C DENND3 SH3PXD2A MACF1 OSMR SGF29 CACNA2D3 ANKS1A | 1.60e-03 | 1113 | 133 | 13 | EFO_0004840 |
| Disease | triglycerides to total lipids in very large VLDL percentage | 1.78e-03 | 53 | 133 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 1.78e-03 | 53 | 133 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.88e-03 | 54 | 133 | 3 | EFO_0022244 | |
| Disease | 3-hydroxyanthranilic acid measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0010447 | |
| Disease | immature platelet measurement | 2.10e-03 | 119 | 133 | 4 | EFO_0803541 | |
| Disease | Hypertrophic Cardiomyopathy | 2.19e-03 | 57 | 133 | 3 | C0007194 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.23e-03 | 121 | 133 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | retinal vasculature measurement | 2.44e-03 | 517 | 133 | 8 | EFO_0010554 | |
| Disease | total lipids in VLDL measurement | 2.54e-03 | 60 | 133 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.54e-03 | 60 | 133 | 3 | EFO_0022233 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.66e-03 | 127 | 133 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | docosahexaenoic acid measurement | 2.66e-03 | 127 | 133 | 4 | EFO_0007761 | |
| Disease | free cholesterol in very large VLDL measurement | 2.66e-03 | 61 | 133 | 3 | EFO_0022274 | |
| Disease | reticulocyte count | MYO1G IQGAP2 JMJD1C DENND3 TRIM10 MICAL2 NISCH SLC22A4 SLC22A5 PRKAR1A OSMR GAA | 2.77e-03 | 1045 | 133 | 12 | EFO_0007986 |
| Disease | free cholesterol in very large HDL measurement | 2.79e-03 | 62 | 133 | 3 | EFO_0022273 | |
| Disease | cholesterol in large VLDL measurement | 3.19e-03 | 65 | 133 | 3 | EFO_0021902 | |
| Disease | Hydrops Fetalis | 3.28e-03 | 19 | 133 | 2 | C0020305 | |
| Disease | oleoylcarnitine measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0021043 | |
| Disease | response to methotrexate, neurotoxicity | 3.28e-03 | 19 | 133 | 2 | EFO_0011057, GO_0031427 | |
| Disease | breast carcinoma (is_marker_for) | 3.33e-03 | 66 | 133 | 3 | DOID:3459 (is_marker_for) | |
| Disease | schizophrenia (implicated_via_orthology) | 3.62e-03 | 68 | 133 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | free cholesterol in large VLDL measurement | 3.62e-03 | 68 | 133 | 3 | EFO_0022265 | |
| Disease | phospholipids:total lipids ratio | 3.74e-03 | 227 | 133 | 5 | EFO_0020946 | |
| Disease | mitochondrial DNA measurement | 3.80e-03 | 328 | 133 | 6 | EFO_0006312 | |
| Disease | lung cancer | 4.00e-03 | 21 | 133 | 2 | MONDO_0008903 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 4.00e-03 | 21 | 133 | 2 | EFO_0022262 | |
| Disease | metabolite measurement, diet measurement | 4.09e-03 | 71 | 133 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | perceived unattractiveness to mosquitos measurement | 4.26e-03 | 72 | 133 | 3 | EFO_0008380 | |
| Disease | otitis media (implicated_via_orthology) | 4.39e-03 | 22 | 133 | 2 | DOID:10754 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WTANTLDAVVVGVDY | 131 | Q6P093 | |
| TNVTNITWYVNDVPT | 161 | A8MTB9 | |
| WTTVLYNTNDALGAT | 311 | Q15878 | |
| YIDSSINNVSSGDVW | 106 | Q2M2I8 | |
| YQVNLTASLGTWDVA | 176 | Q00973 | |
| ATPWDQVSYVSQVSL | 1416 | P35670 | |
| TSTQEVVQYNWETGD | 71 | Q2KHT4 | |
| DQQAIISGESIYWSQ | 1161 | A8K2U0 | |
| ITTIEWNDVTLYQAF | 66 | Q9BZP6 | |
| FNVYGITEVSSWATI | 341 | Q4L235 | |
| VGEWLESIGLQQYES | 701 | Q92625 | |
| QNQVWVGSEDSVIYI | 956 | A2RUS2 | |
| ELDVSGILATQVYTW | 2666 | Q9Y485 | |
| GILATQVYTWVDDDI | 2671 | Q9Y485 | |
| GYVIVSSVSWAVTNE | 31 | Q8IUH2 | |
| NGLVATEVSTWFYVR | 76 | Q7Z4Y8 | |
| VITVNFQIGLDTSYW | 1081 | O43520 | |
| VYATSTWGELTQTLG | 81 | Q8TD07 | |
| ISRIETSNVIWVGNY | 71 | Q99650 | |
| TIQGYDAIVVEQWTV | 366 | Q14699 | |
| LQNVTATSANITWVY | 1001 | A6NNM3 | |
| LQNVTATSANITWVY | 1001 | A6NJZ7 | |
| QLESVSNGWTVYRIA | 516 | Q9NVH2 | |
| VTVEGYWQITVDSIT | 246 | P0DJD9 | |
| GVQIQESTSWNEYTF | 156 | P23467 | |
| VFLENVIWYAVTNTE | 61 | Q99525 | |
| LKDVVAYVEVWSSNG | 6 | Q8NEM0 | |
| DWHQTDSLVVVTVYG | 221 | Q9UKP3 | |
| NVDLYELGSTSVQQW | 356 | Q9NRM7 | |
| VVGTTALYLVEEAWA | 101 | F2Z398 | |
| VYRQDSATQWFTGII | 196 | Q15652 | |
| ESAGYVEVQVWRTGT | 2021 | Q5SZK8 | |
| VVPESDSNSQVDWTY | 341 | Q9NXR8 | |
| TWEITQTQYILEGYS | 1496 | A6NKB5 | |
| SAVVVTWESVAPYQG | 151 | P14543 | |
| DYTTSAQLQDVVVTW | 46 | Q86SU0 | |
| EVVQVRWTDGQVYGA | 961 | O75164 | |
| ESTVASWYEQGILEN | 546 | P18074 | |
| ESLAVAQNTYAVSWF | 151 | Q9H3U5 | |
| RDYWVITVLQGVDNS | 1056 | Q6ZVL6 | |
| QAIKGVYSSWVTDNI | 76 | A2A3K4 | |
| GTSYQQWLSSVETLL | 221 | O94927 | |
| VVVSLTEGTAVSEYW | 896 | Q86UT6 | |
| VVAVDADSGYNAWLS | 591 | Q9Y5G1 | |
| VTQGLVTRAYTDELW | 351 | Q8TAG9 | |
| AVWVAVETSAYQVEL | 171 | Q8N8X9 | |
| TVEAYSAAVQSQLQW | 756 | Q9UPN3 | |
| TTDWQGQYVAELLQD | 571 | Q6VY07 | |
| VTVEGYWQITVDSIT | 246 | P0DJD8 | |
| IQANYTVGADSWAID | 1746 | P78509 | |
| SEYEIWVSAVNSIGQ | 396 | Q13332 | |
| AIQQTYSWTNQIDIS | 551 | Q9BX63 | |
| QITAQAWDGTTDYQV | 341 | O43719 | |
| EVAQAQTEVTWYKDG | 1281 | Q5VST9 | |
| QVATAVQWTKAEGSY | 981 | P08648 | |
| IIQSGSALSSWAVNY | 311 | Q9NZ94 | |
| VQSYNSDINEWSLIT | 436 | Q8NBE8 | |
| LVSGEIYGTNSEWET | 186 | O95393 | |
| YSRVLGVSDVITWND | 691 | Q8TDB6 | |
| VNGVYWSESLNKVFV | 186 | Q8IZS8 | |
| EVYSNTLAGVWVTTG | 611 | Q86XK2 | |
| DLSINDTSVTVIWYG | 216 | Q8NCQ5 | |
| THYTQVVWATSNRIG | 166 | Q9H336 | |
| VDAWASVTEELGAQY | 151 | P07902 | |
| AHSYAIVWVNGVDTL | 126 | P08236 | |
| SFYWQGQLISDQVAE | 206 | P06756 | |
| EGSLELSWNVSYTQE | 56 | P09172 | |
| DSGTYQVAITINSEW | 116 | Q7Z692 | |
| NSYWRVSTVHGNVIT | 26 | P56746 | |
| WGYSSTAITRQVVEN | 376 | P10253 | |
| DQAGVSVLYTVTLWV | 101 | P42701 | |
| VYDAGTWAVTQLAVS | 421 | Q6ZNC8 | |
| WSSATEAVPDVYQVS | 691 | P49641 | |
| ETDVYVNNEWATSVG | 181 | P10644 | |
| EVDVYVNGEWVTNIS | 181 | P31321 | |
| GQQSDYAVSEPVWIT | 1566 | Q9ULL0 | |
| YETQSAADWTVQIVV | 626 | A4D0S4 | |
| TTNLSAYQSVQETWL | 296 | Q53GD3 | |
| ELQISAVWSEDTGSY | 161 | Q96LA5 | |
| GYVSDTETSVVWNNE | 566 | Q8NBJ5 | |
| SNTISIIGDYNWTNL | 546 | P54803 | |
| NTVGEWQTVFYIAAA | 451 | Q9NRA2 | |
| GWEFSQDVYLSTVVT | 116 | Q9H015 | |
| GWEFSQDVYLSTIVT | 116 | O76082 | |
| VWFTDNLEAAATYVQ | 121 | Q8NFZ4 | |
| SLEVATQYGWVLDAE | 511 | Q969Z0 | |
| EGYQHVNVTDLTTSW | 531 | O94851 | |
| QALSVADTSVYGWAT | 1661 | Q5VU65 | |
| VQGEWNSVLEFTYSN | 631 | Q9BXB4 | |
| VTVEGYWQITVDSIT | 246 | P0DJD7 | |
| QISISWASEIGKNYS | 276 | O75928 | |
| DSGDWVLLNVYDSIQ | 791 | Q9P2E2 | |
| TVSTYVIRDEWGNQI | 851 | Q5VWG9 | |
| WGTVSSYNVLVDKET | 326 | O15034 | |
| DSWYVILNGTVEISH | 316 | Q8TEU7 | |
| TYSRAGVSVWVQAVE | 46 | Q9Y365 | |
| TWSHQIGDSYRDVIQ | 901 | Q9P0V3 | |
| VAEAGWNLYIVNTIS | 481 | Q969F9 | |
| IDAWDITIAYGTNNV | 511 | Q6UWF7 | |
| LQNVTATSANITWVY | 1001 | Q9UFD9 | |
| EVTVGYIRENIWSAS | 646 | Q13576 | |
| YAVVGTVWNAATTGL | 146 | P48764 | |
| VDIWSAGVTLYNITT | 236 | Q15831 | |
| SVWITIYQNSTDVFQ | 761 | Q5T5J6 | |
| TDVASAWTENYGLQE | 191 | Q6ZWJ1 | |
| AVDENGLWVIYSTEA | 386 | Q6UX06 | |
| NISQNYISELWTSDI | 51 | Q15399 | |
| HVDAIEQQWTGTRSY | 441 | Q495B1 | |
| NTIVVNWSSEFGRNY | 256 | Q9Y6X2 | |
| ATNANVIAVDWIYGS | 111 | Q53H76 | |
| DSWSVILNGSVEVTY | 171 | Q9Y4G8 | |
| GVWEKTVNTEENVYA | 21 | P40200 | |
| AQQLWYAIIESQTET | 386 | P23921 | |
| SVYQELFITWNGEIS | 86 | Q8NE28 | |
| YGNSVLVSIVNVVWT | 76 | Q9NYW1 | |
| GDEQWILAEVVSYSH | 171 | Q96ES7 | |
| YIINVTWSDSTSQTI | 26 | Q5TCZ1 | |
| TEVTQAIWDGYLQQA | 211 | Q9NUY8 | |
| SYDGEIVLWNNSTEN | 301 | Q8IV35 | |
| TVYIIQVTDGSHEWT | 31 | Q9Y2I1 | |
| VAVYFTQNEWASLDS | 16 | Q6ZNG0 | |
| VITYAIGVAWAAQEE | 621 | Q6UXI7 | |
| SELTVVNNGTVAIWY | 446 | Q8TBZ2 | |
| WQEGEEIVITTTSYD | 3191 | Q86WI1 | |
| VLGEVYLHTWITENT | 691 | Q9UKN8 | |
| TALSNITVETYNDWG | 1411 | Q14997 | |
| QEYWNITDLVAISTF | 896 | Q7Z4N2 | |
| ILTDQCLTYEQITGW | 371 | A7E2V4 | |
| DYEVGWVTFTNAVTR | 436 | Q9UDY6 | |
| TLYATDLGQQVSWTT | 131 | Q5HYJ1 | |
| LYQLTTAGEAVSWNS | 251 | Q5BJD5 | |
| NLVASGANESEIYIW | 136 | O94979 | |
| SVYDNLSPVVTTWQN | 111 | O95363 | |
| ADVVSTTENVAVYIW | 101 | Q03393 | |
| TENQEVSTGVKWENY | 626 | Q9UPU7 | |
| SGSEDNLVYIWNLQT | 276 | P61964 | |
| DNLYTVQSDVWAFGV | 706 | Q06418 | |
| QISEETWNFLQSIYG | 896 | Q8TEY7 | |
| SGAAAATTVAWYQVS | 116 | P30536 | |
| SNIYWTDSVLGTVSV | 486 | P01130 | |
| TWQSVEYFNNATIVD | 441 | B0I1T2 | |
| SQDGAQSLVTLWSYN | 236 | Q96L15 | |
| VQATYISGELVWQAD | 391 | Q9Y303 | |
| VEYLSWEVTGECNVL | 1361 | P52179 |